PANDY vs. NVO

Last updated Apr 1, 2026

Compare and contrast key facts about Pandora A/S ADR (PANDY) and Novo Nordisk A/S (NVO).

Performance

PANDY vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pandora A/S ADR (PANDY) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

PANDY vs. NVO - Yearly Performance Comparison

	2026 (YTD)
PANDY Pandora A/S ADR	0.00%
NVO Novo Nordisk A/S	-20.03%

Fundamentals

Total Revenue (TTM) PANDY : $31.68B NVO : $297.20B
Gross Profit (TTM) PANDY : $25.29B NVO : $240.66B
EBITDA (TTM) PANDY : $10.08B NVO : $153.18B

Returns By Period

PANDY

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NVO

• 1D: 4.14%
• 1M: 1.73%
• YTD: -25.12%
• 6M: -31.34%
• 1Y: -44.52%
• 3Y*: -20.64%
• 5Y*: 3.88%
• 10Y*: 5.13%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PANDY vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO

NVO Risk / Return Rank: 12
NVO Sharpe Ratio Rank: 8
NVO Sortino Ratio Rank: 11
NVO Omega Ratio Rank: 11
NVO Calmar Ratio Rank: 14
NVO Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PANDY vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pandora A/S ADR (PANDY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	PANDY	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.82	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.10	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.16	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.46	—

Dividends

PANDY vs. NVO - Dividend Comparison

PANDY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 5.06%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PANDY Pandora A/S ADR	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	5.06%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Drawdowns

PANDY vs. NVO - Drawdown Comparison

The maximum PANDY drawdown since its inception was 0.00%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for PANDY and NVO.

Drawdown Indicators

	PANDY	NVO	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-74.70%	+74.70%
Max Drawdown (1Y) Largest decline over 1 year	—	-55.03%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-74.70%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-74.70%	—
Current Drawdown Current decline from peak	0.00%	-73.25%	+73.25%
Average Drawdown Average peak-to-trough decline	0.00%	-17.55%	+17.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	31.69%	—

Volatility

Volatility by Period

	PANDY	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.88%	—
Volatility (6M) Calculated over the trailing 6-month period	—	38.79%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	54.20%	-54.20%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	37.82%	-37.82%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	32.29%	-32.29%

Financials